glp-1 препараты Агонисты рецепторов глюкагоноподобного пептида (ГПП) - список препаратов из 15.03 входит в группу клинико-фармакологических указателей (КФУ) 15 Пока страховщики борются с расходами

It is not widely prescribed

Sustainable weight maintenance after Zepbound requires permanent lifestyle modifications rather than temporary dietary changes

I am confident the pharmaceutical industry will not be funding these trials

Food noise significantly reduced for most

With newer GLP-1based therapies now emerging, the field has an opportunity to test whether different drugs in this class have distinct effects on aging biology and to identify which patients may benefit most. Larger clinical trials will be needed to confirm these findings, determine how long the effects persist, and establish optimal dosing strategies and treatment durations for both people with HIV and the broader population

Es genial y no me hace dao